secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001640334-26-000181
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences reports reconvened annual meeting results; directors re-elected, say-on-pay and auditor ratified
--------------------------------------------------------------------------------

- Quorum achieved with 1,017,816 of 2,018,746 outstanding shares (50.4%) at reconvened meeting on Jan 30, 2026.
- Class II directors Douglas Blayney (248,985 votes for) and Connie Matsui (257,384) re-elected.
- Advisory say-on-pay passed with 158,971 for, 126,089 against, 103,377 abstaining.
- Ratification of Malone Bailey LLP as auditor for FY 2026 approved: 830,673 for, 85,078 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000181/0001640334-26-000181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000181/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer